noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Fastly Inc.

Notice of Proposed Sale of Securities (Form 144)
City of Riverside, CA

City of Riverside Names Nathan Mustafa Director of Public Works
The Office of the Governor of the[...]

Trump sticks Taxpayers with $111 million bill for his illegal[...]

Healthcare

Monopar Therapeutics Inc.

05/19/2026 | Press release | Distributed by Public on 05/19/2026 15:38

Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease

Monopar Therapeutics Inc. published this content on May 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 19, 2026 at 21:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]